Focus AI completes acquisition of Busan Digital Asset Exchange and becomes its largest shareholder
PANews, February 27 — According to NEWSPIM, Focus AI has announced the completion of the remaining payment for the acquisition of Busan Digital Asset Exchange. Focus AI ultimately acquired 40.61% of the shares, officially becoming its largest shareholder and obtaining management rights. Busan Digital Asset Exchange is Korea's first RWA tokenization exchange, currently supporting 23-hour digital trading of seven types of physical precious metal assets, including gold, silver, and platinum. The KDX Alliance, in which it participates, recently received the first preliminary license for OTC securities trading brokerage of STOs from the Financial Services Commission (FSC) of Korea. Through this acquisition, Focus AI plans to integrate AI, payment, stablecoin, and e-wallet technologies to build Web3 payment platform infrastructure and promote the development of RWA and STO businesses.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BNP Paribas gives Microsoft (MSFT.US) a "Buy" rating: Azure price increases will be gradually implemented after contract renewals, and a deal with SpaceX may be announced soon.
BNP Paribas has rated Microsoft as "Buy" with a target price of $549.
Iranian President will head to New York for UN meeting
"Big Short" Burry opens a position in QXO (QXO.US), betting on building products integration and undervaluation; stock price rises over 7%
Investor Michael Burry disclosed that he has purchased common and preferred shares of QXO (QXO.US), a building products company, citing its integration strategy and the currently depressed stock price. The stock surged 7.2% on Monday.
700,000 new elderly patients join, Eli Lilly (LLY.US) dominates 70%: The first Medicare weight loss drug coverage report released
Dave Ricks, CEO of Eli Lilly (LLY.US), said in an interview on Monday that since Medicare began coverage for obesity drugs in July, 700,000 new elderly patients have started using GLP-1 medications.
